title: Neoadjuvant and adjuvant chemotherapy in advanced disease--what are the effects on survival and prognosis?
authors.forename: C N
authors.initials: CN
authors.lastname: Sternberg
authors.forename: D
authors.initials: D
authors.lastname: Raghaven
authors.forename: Y
authors.initials: Y
authors.lastname: Ohi
authors.forename: D
authors.initials: D
authors.lastname: Bajorin
authors.forename: H
authors.initials: H
authors.lastname: Herr
authors.forename: T
authors.initials: T
authors.lastname: Kato
authors.forename: M
authors.initials: M
authors.lastname: Kuroda
authors.forename: C H
authors.initials: CH
authors.lastname: Logothetis
authors.forename: H
authors.initials: H
authors.lastname: Scher
authors.forename: T A
authors.initials: TA
authors.lastname: Splinter
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D006801:Humans; D011379:Prognosis; D015996:Survival Rate; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000401:mortality